Published in Gut on February 01, 1998
Helicobacter pylori persistence: biology and disease. J Clin Invest (2004) 4.75
The importance of interleukin 1beta in Helicobacter pylori associated disease. Gut (2001) 2.02
Cancer and inflammation: promise for biologic therapy. J Immunother (2010) 1.72
Interleukin-1beta promotes gastric atrophy through suppression of Sonic Hedgehog. Gastroenterology (2009) 1.58
Multifactorial etiology of gastric cancer. Methods Mol Biol (2012) 1.29
Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils. Gut (2001) 1.27
Role of proinflammatory cytokines in the impaired lacrimation associated with autoimmune xerophthalmia. Invest Ophthalmol Vis Sci (2002) 1.22
How Helicobacter pylori infection controls gastric acid secretion. J Gastroenterol (2012) 0.99
The polymorphic IL-1B and IL-1RN genes in the aetiopathogenesis of peptic ulcer. Clin Exp Immunol (2001) 0.99
Novel insight in the association between salmonellosis or campylobacteriosis and chronic illness, and the role of host genetics in susceptibility to these diseases. Epidemiol Infect (2007) 0.96
Molecular epidemiology of gastric cancer: current status and future prospects. Gastrointest Cancer Res (2007) 0.96
The local immune response of mice after Helicobacter suis infection: strain differences and distinction with Helicobacter pylori. Vet Res (2012) 0.95
Association between TNF α gene polymorphisms and the risk of duodenal ulcer: a meta-analysis. PLoS One (2013) 0.93
Inhibition of carbachol stimulated acid secretion by interleukin 1beta in rabbit parietal cells requires protein kinase C. Gut (2001) 0.93
Macrophages promote progression of spasmolytic polypeptide-expressing metaplasia after acute loss of parietal cells. Gastroenterology (2014) 0.93
Interleukin 1beta induces gastric epithelial cell matrix metalloproteinase secretion and activation during Helicobacter pylori infection. Gut (2003) 0.92
Influence of inflammatory cytokine polymorphisms on eradication rates of Helicobacter pylori. J Gastroenterol Hepatol (2009) 0.92
Molecular epidemiology of genetic susceptibility to gastric cancer: focus on single nucleotide polymorphisms in gastric carcinogenesis. Am J Transl Res (2009) 0.92
Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy. Gut (2005) 0.91
Host factors are important in determining clinical outcomes of Helicobacter pylori infection. J Gastroenterol (2006) 0.91
Virulence factor genotypes of Helicobacter pylori affect cure rates of eradication therapy. Arch Immunol Ther Exp (Warsz) (2009) 0.91
Plasma leptin and ghrelin concentrations in patients with Crohn's disease. World J Gastroenterol (2005) 0.90
Association of interleukin 1 gene family polymorphisms with duodenal ulcer disease. Clin Exp Immunol (2003) 0.90
The role of obesity in oesophageal cancer development. Therap Adv Gastroenterol (2014) 0.90
Helicobacter pylori-related chronic gastritis as a risk factor for colonic neoplasms. World J Gastroenterol (2014) 0.88
Mechanisms of increased acid secretion after eradication of Helicobacter pylori infection. Gut (2006) 0.88
Enhanced production of leptin in gastric fundic mucosa with Helicobacter pylori infection. World J Gastroenterol (2005) 0.86
Effect of interlukin-1beta on proliferation of gastric epithelial cells in culture. BMC Gastroenterol (2002) 0.86
Factors that mediate colonization of the human stomach by Helicobacter pylori. World J Gastroenterol (2014) 0.86
Increased gastric IL-1β concentration and iron deficiency parameters in H. pylori infected children. PLoS One (2013) 0.85
Effect of Th1 cytokines on acid secretion in pharmacologically characterised mouse gastric glands. Gut (2004) 0.85
Helicobacter felis infection is associated with lymphoid follicular hyperplasia and mild gastritis but normal gastric secretory function in cats. Infect Immun (2000) 0.84
Pathophysiological mechanisms linking obesity and esophageal adenocarcinoma. World J Gastrointest Pathophysiol (2014) 0.84
Causal role of Helicobacter pylori infection in gastric cancer. World J Gastroenterol (2006) 0.84
A functional polymorphism in the interleukin-1 receptor-1 gene is associated with increased risk of Helicobacter pylori infection but not with gastric cancer. Dig Dis Sci (2004) 0.84
Eradication of Helicobacter pylori infection improves levodopa action, clinical symptoms and quality of life in patients with Parkinson's disease. PLoS One (2014) 0.83
Eradication rate of Helicobacter pylori according to genotypes of CYP2C19, IL-1B, and TNF-A. Int J Med Sci (2006) 0.82
Effects of pro-inflammatory cytokines on acid secretion. Dig Dis Sci (2000) 0.82
No relationship between IL-1B gene polymorphism and gastric acid secretion in younger healthy volunteers. World J Gastroenterol (2005) 0.81
Unintended consequences of Helicobacter pylori infection in children in developing countries: iron deficiency, diarrhea, and growth retardation. Gut Microbes (2013) 0.81
Helicobacter pylori: bacterial factors and the role of cytokines in the immune response. Curr Microbiol (2009) 0.81
Relationship between IL-1beta gene polymorphism and gastric mucosal IL-1beta levels in patients with Helicobacter pylori infection. J Gastroenterol (2005) 0.81
Helicobacter pylori infection and drugs malabsorption. World J Gastroenterol (2014) 0.80
Correlations among gastric juice pH and ammonia, Helicobacter pylori infection and gastric mucosal histology. Korean J Intern Med (2004) 0.80
Sustained epithelial proliferation in a functionally irreversible fundic mucosa after Helicobacter pylori eradication. J Gastroenterol (2009) 0.80
H pylori seropositivity and cytokine gene polymorphisms. World J Gastroenterol (2007) 0.80
Role of tumor necrosis factor-α -308 G/A promoter polymorphism in gastric cancer. Saudi J Gastroenterol (2013) 0.80
Association of haplotypes of inflammation-related genes with gastric preneoplastic lesions in African Americans and Caucasians. Int J Cancer (2011) 0.80
Effect of purified lipopolysaccharides from strains of Helicobacter pylori and Helicobacter felis on acid secretion in mouse gastric glands in vitro. Infect Immun (2001) 0.80
Helicobacter pylori protein JHP0290 binds to multiple cell types and induces macrophage apoptosis via tumor necrosis factor (TNF)-dependent and independent pathways. PLoS One (2013) 0.79
Role of γ-glutamyltranspeptidase in the pathogenesis of Helicobacter suis and Helicobacter pylori infections. Vet Res (2015) 0.79
Molecular and histological evaluation of tumor necrosis factor-alpha expression in Helicobacter pylori-mediated gastric carcinogenesis. J Cancer Res Clin Oncol (2010) 0.79
Helicobacter pylori infection and gastric carcinoma: Not all the strains and patients are alike. World J Gastrointest Oncol (2016) 0.79
Association between TNFA Gene Polymorphisms and Helicobacter pylori Infection: A Meta-Analysis. PLoS One (2016) 0.78
Analysis of cell hyperplasia and parietal cell dysfunction induced by Ostertagia ostertagi infection. Vet Res (2013) 0.78
Associations of TNF-A-1031TT and -857TT genotypes with Helicobacter pylori seropositivity and gastric atrophy among Japanese Brazilians. Int J Clin Oncol (2006) 0.78
Interleukin-1B signalling leads to increased survival of gastric carcinoma cells through a CREB-C/EBPβ-associated mechanism. Gastric Cancer (2015) 0.78
At the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer. J Leukoc Biol (2014) 0.78
TLR-independent induction of human monocyte IL-1 by phosphoglycolipids from thermophilic bacteria. Glycoconj J (2007) 0.77
Cytokines, cytokine gene polymorphisms and Helicobacter pylori infection: friend or foe? World J Gastroenterol (2014) 0.77
Expression of cytokeratins in Helicobacter pylori-associated chronic gastritis of adult patients infected with cagA+ strains: an immunohistochemical study. World J Gastroenterol (2006) 0.77
Inhibition of small-conductance Cl- channels by the interleukin-1beta-stimulated production of superoxide in rabbit gastric parietal cells. J Physiol (2003) 0.77
Interleukin-1 gene polymorphisms in chronic gastritis patients infected with Helicobacter pylori as risk factors of gastric cancer development. Arch Immunol Ther Exp (Warsz) (2013) 0.76
Association between interleukin-1beta-511C/T polymorphism and reflux esophagitis in Japan. J Gastroenterol (2005) 0.76
Effect of bacterial and host factors on Helicobacter pylori eradication therapy. Expert Opin Ther Targets (2015) 0.76
Interleukin-1B 31 C>T polymorphism combined with Helicobacter pylori-modified gastric cancer susceptibility: evidence from 37 studies. J Cell Mol Med (2016) 0.75
Protein kinase C-alpha attenuates cholinergically stimulated gastric acid secretion of rabbit parietal cells. Br J Pharmacol (2003) 0.75
Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction. PLoS One (2016) 0.75
Effects of pentoxifylline on alcohol-induced gastric injury and acid secretion in rats. Dig Dis Sci (2003) 0.75
Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods (1986) 12.51
Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust (1985) 10.75
Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab Invest (1987) 7.95
Interleukin-1 and interleukin-1 antagonism. Blood (1991) 7.67
Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol (1987) 7.09
G proteins: a family of signal transducers. Annu Rev Cell Biol (1986) 5.38
Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology (1992) 4.63
Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci U S A (1987) 3.88
Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut (1991) 3.82
Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology (1995) 3.28
Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol (1994) 3.22
Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem (1991) 3.06
Epidemic gastritis with hypochlorhydria. Gastroenterology (1979) 2.65
The actions of secretagogues on oxygen uptake by isolated mammalian parietal cells. J Clin Invest (1978) 2.53
Iatrogenic Campylobacter pylori infection is a cause of epidemic achlorhydria. Am J Gastroenterol (1988) 1.97
Effects of secretagogues on oxygen consumption, aminopyrine accumulation and morphology in isolated gastric glands. Acta Physiol Scand (1976) 1.97
Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J Immunol (1993) 1.89
Secretagogue stimulation of [14C]aminopyrine accumulation by isolated canine parietal cells. Am J Physiol (1980) 1.88
Secretagogue-specific effects of interleukin-1 on gastric acid secretion. Am J Physiol (1991) 1.45
Interleukin-1 is cytoprotective, antisecretory, stimulates PGE2 synthesis by the stomach, and retards gastric emptying. Life Sci (1991) 1.39
Gastrin receptors on isolated canine parietal cells. J Clin Invest (1984) 1.30
Molecular cloning of a gene encoding the histamine H2 receptor. Proc Natl Acad Sci U S A (1991) 1.25
Histamine responsiveness of isolated gastric glands. Am J Physiol (1980) 1.25
Primary culture of secretagogue-responsive parietal cells from rabbit gastric mucosa. Am J Physiol (1989) 1.13
Interleukin-1 beta inhibits gastric histamine secretion and synthesis in the rat. Am J Physiol (1994) 1.11
Inhibitors of protein tyrosine kinase suppress TNF-stimulated induction of endothelial cell adhesion molecules. J Immunol (1995) 1.08
Central action of recombinant interleukin-1 to inhibit acid secretion in rats. Gastroenterology (1990) 1.04
Mechanisms for direct inhibition of canine gastric parietal cells by somatostatin. J Biol Chem (1987) 1.02
Distribution of Helicobacter pylori colonisation and associated gastric inflammatory changes: difference between patients with duodenal and gastric ulcers. J Clin Pathol (1993) 0.98
Mechanisms underlying the protective effects of interleukin 1 in experimental nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology (1992) 0.93
Autoregulation of muscarinic and gastrin receptors on gastric parietal cells. Am J Physiol (1989) 0.91
The effect of recombinant cytokines on [14C]-aminopyrine accumulation by isolated canine parietal cells. J Pharmacol Exp Ther (1994) 0.90
Epidermal growth factor inhibits carbachol-stimulated canine parietal cell function via protein kinase C. Gastroenterology (1996) 0.85
Epidermal growth factor and transforming growth factor-alpha directly inhibit parietal cell function through a similar mechanism. J Pharmacol Exp Ther (1993) 0.84
Carbonic anhydrase II gene expression in isolated canine gastric parietal cells. Am J Physiol (1989) 0.82
General pharmacology of recombinant human tumor necrosis factor. 1st communication: effects on cardiovascular, gastrointestinal, renal and blood functions. Arzneimittelforschung (1990) 0.82
Multiple actions of epidermal growth factor and TGF-alpha on rabbit gastric parietal cell function. Am J Physiol (1994) 0.81
Helicobacter pylori. Eur J Clin Invest (1994) 0.80
Tumor necrosis factor and interleukin 1 inhibit parathyroid hormone-responsive adenylate cyclase in clonal osteoblast-like cells by down-regulating parathyroid hormone receptors. J Cell Physiol (1992) 0.80
Interleukin-1 inhibits stress-induced gastric erosion in rats. Life Sci (1991) 0.80
Carbamoylcholine and gastrin induce inositol lipid turnover in canine gastric parietal cells. Am J Physiol (1988) 0.79
G proteins in clinical medicine. Hosp Pract (Off Ed) (1988) 0.79
Interleukin-1 and experimental gastric ulcer healing in the rat. J Physiol Pharmacol (1993) 0.79
Reduction of the severity of experimental gastric and duodenal ulceration by interleukin-1 beta. Eur J Pharmacol (1990) 0.78
Platelet-activating factor stimulates gastric acid secretion in isolated rabbit gastric glands. Am J Physiol (1995) 0.78
Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet (1989) 9.76
Effect of luminal growth factor preservation on intestinal growth. Lancet (1993) 3.25
Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut (1996) 2.58
Helicobacter pylori and peptic ulcers: the present position. Gut (1992) 2.27
Saturation of fat and cholecystokinin release: implications for pancreatic carcinogenesis. Lancet (1989) 2.25
ABC of the upper gastrointestinal tract: Pathophysiology of duodenal and gastric ulcer and gastric cancer. BMJ (2001) 1.99
Cytokine gene expression in Helicobacter pylori associated antral gastritis. Gut (1994) 1.97
Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet (1992) 1.88
Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori. Gut (1993) 1.85
Vicia faba agglutinin, the lectin present in broad beans, stimulates differentiation of undifferentiated colon cancer cells. Gut (1999) 1.75
Antral vascular lesion, achlorhydria, and chronic gastrointestinal blood loss: response to steroids. Dig Dis Sci (1980) 1.68
Antral Helicobacter pylori, hypergastrinaemia, and duodenal ulcers: effect of eradicating the organism. BMJ (1989) 1.48
Portal vein thrombosis in myeloproliferative disease. Uses of thrombolytic and antiplatelet treatment. BMJ (1990) 1.43
Preliminary report: role of peptide YY in defence against diarrhoea. Lancet (1990) 1.37
Epidermal growth factor is digested to smaller, less active forms in acidic gastric juice. Gastroenterology (1995) 1.35
Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection. Eur J Gastroenterol Hepatol (1996) 1.30
Identification and measurement of molecular variants of cholecystokinin in duodenal mucosa and plasma. Diminished concentrations in patients with celiac disease. J Clin Invest (1982) 1.22
Family studies of hypergastrinemic, hyperpepsinogenemic I duodenal ulcer. Ann Intern Med (1981) 1.21
Mesalazine induced interstitial nephritis. Gut (1994) 1.14
Suppression of Helicobacter pylori reduces gastrin releasing peptide stimulated gastrin release in duodenal ulcer patients. Gut (1992) 1.13
Nalpha-methyl histamine and histamine stimulate gastrin release from rabbit G-cells via histamine H2-receptors. Aliment Pharmacol Ther (1999) 1.13
The effect of gastrin-releasing peptide on gastrin and somatostatin messenger RNAs in humans infected with Helicobacter pylori. Gastroenterology (1997) 1.10
Big and little gastrin responses to food in normal and ulcer subjects. Gut (1979) 1.10
Gastric antral vascular ectasia: maintenance treatment with oestrogen-progesterone. Gut (1992) 1.09
Campylobacter pylori, duodenal ulcer disease, and gastrin. BMJ (1989) 1.06
Pancreatic secretory trypsin inhibitor stimulates the growth of rat pancreatic carcinoma cells. Gastroenterology (1990) 1.05
Postprandial hypergastrinaemia in patients with colorectal cancer. Gut (1991) 1.05
Effect of transforming growth factor alpha and interleukin 8 on somatostatin release from canine fundic D cells. Gastroenterology (1997) 1.02
Gastric output of pancreatic secretory trypsin inhibitor is increased by misoprostol. Gut (1991) 1.02
Inhibitory effect of a cholecystokinin antagonist on the proliferative response of the pancreas to pancreatobiliary diversion. Gut (1991) 1.01
Effect of peptide YY on human renal function. Am J Physiol (1995) 1.00
Molecular forms of gastrin in peptic ulcer: comparison of serum and tissue concentrations of G17 and G34 in gastric and duodenal ulcer subjects. Eur J Clin Invest (1980) 0.99
Pancreatic secretory trypsin inhibitor in gastrointestinal mucosa and gastric juice. Gut (1990) 0.99
Campylobacter pylori, gastrin, acid secretion, and duodenal ulcers. Lancet (1989) 0.98
Stimulation of IL-8 production in human gastric epithelial cells by Helicobacter pylori, IL-1beta and TNF-alpha requires tyrosine kinase activity, but not protein kinase C. Cytokine (1997) 0.97
Tumour necrosis factor alpha stimulates gastrin release from canine and human antral G cells: possible mechanism of the Helicobacter pylori-gastrin link. Eur J Clin Invest (1996) 0.96
Tropic role of enteroglucagon in pancreatic adaptation to subtotal enterectomy. Br J Surg (1991) 0.96
Long-term sequelae of Helicobacter pylori gastritis. Lancet (1995) 0.95
Systemic candidiasis: an unusual complication of eating mutton. BMJ (1989) 0.95
Effect of Helicobacter pylori products and recombinant cytokines on gastrin release from cultured canine G cells. Gastroenterology (1997) 0.95
Duodenogastric reflux enhances growth and carcinogenesis in the rat pancreas. Br J Surg (1992) 0.94
Dose-dependent effects of fentanyl on indomethacin-induced gastric damage. Digestion (1991) 0.94
Seasonality of ulcerative colitis. Lancet (1984) 0.94
Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis. Aliment Pharmacol Ther (1996) 0.94
Influence of inflammation and atrophy on pancreatic secretory trypsin inhibitor levels within the gastric mucosa. Gastroenterology (1994) 0.94
Inhibitory effect of a cholecystokinin antagonist on pancreatic carcinogenesis after pancreatobiliary diversion. Br J Cancer (1993) 0.93
Inhibition of carbachol stimulated acid secretion by interleukin 1beta in rabbit parietal cells requires protein kinase C. Gut (2001) 0.93
Role of cholecystokinin in pancreatic adaptation to massive enterectomy. Gut (1992) 0.93
Effects of vasoactive intestinal polypeptide on renal function in man. J Physiol (1983) 0.92
Enhancing effect of partial gastrectomy on pancreatic carcinogenesis. Br J Cancer (1992) 0.92
Influence of inflammatory bowel disease on the distribution and concentration of pancreatic secretory trypsin inhibitor within the colon. Am J Pathol (1995) 0.91
Antral Campylobacter pylori colonization, ABO blood group, and secretor status. Gastroenterol Clin Biol (1989) 0.89
Sucralfate diminishes basal acid output without affecting gastrin, H. pylori or gastritis in duodenal ulcer patients. Aliment Pharmacol Ther (1992) 0.89
Is jejunal biopsy valuable in the elderly? Age Ageing (1978) 0.88
Neurotensin stimulates defaecation. Lancet (1983) 0.88
Circulating antibodies to the 60-kD heat shock protein (hsp) family in patients with Helicobacter pylori infection. Clin Exp Immunol (1998) 0.87
Mononuclear cells and cytokines stimulate gastrin release from canine antral cells in primary culture. Am J Physiol (1996) 0.87
SMS 201-995 treatment and advanced intestinal cancer: a pilot study. Aliment Pharmacol Ther (1987) 0.85
Helicobacter felis infection is associated with lymphoid follicular hyperplasia and mild gastritis but normal gastric secretory function in cats. Infect Immun (2000) 0.84
Gastrointestinal responses to a panel of lectins in rats maintained on total parenteral nutrition. Am J Physiol (1999) 0.84
Soybean lectin stimulates pancreatic exocrine secretion via CCK-A receptors in rats. Am J Physiol (1996) 0.83
Truncated glucagon-like peptide-1 and oxyntomodulin stimulate somatostatin release from rabbit fundic D-cells in primary culture. Exp Physiol (1996) 0.83
Acid and gastrin responses during intragastric titration in normal subjects and duodenal ulcer patients with G-cell hyperfunction. Gut (1985) 0.82
Grand rounds--Hammersmith Hospital. Persistent fever in pulmonary tuberculosis. BMJ (1996) 0.82
pH-dependent secretion of gastrin in duodenal ulcer disease: effect of suppressing Helicobacter pylori. Digestion (1992) 0.81
Assessment of gall bladder dynamics, cholecystokinin release and the development of gallstones during octreotide therapy for acromegaly. Q J Med (1992) 0.81
Pyloric reflux and G-cell hyperfunction. Lancet (1980) 0.81
N alpha-methylhistamine: association with Helicobacter pylori infection in humans and effects on gastric acid secretion. Clin Chim Acta (2000) 0.81
Elevated plasma cholecystokinin at high altitude: metabolic implications for the anorexia of acute mountain sickness. High Alt Med Biol (2000) 0.81
Physical exercise and normobaric hypoxia: independent modulators of peripheral cholecystokinin metabolism in man. J Appl Physiol (1985) (2001) 0.81
Bismuth induced encephalopathy caused by tri potassium dicitrato bismuthate in a patient with chronic renal failure. Gut (1990) 0.81
Helicobacter pylori infection in the cat: evaluation of gastric colonization, inflammation and function. Helicobacter (2001) 0.80
Helicobacter pylori increases gastrin release from cultured canine antral G-cells. Eur J Gastroenterol Hepatol (2000) 0.79
Effects of a panel of dietary lectins on cholecystokinin release in rats. Am J Physiol (1997) 0.79
Four-dimensional phosphorus-31 chemical shift imaging of carcinoid metastases in the liver. NMR Biomed (1988) 0.79
Cytoplasmic antineutrophil cytoplasmic antibody-positive vasculitis associated with ulcerative colitis. Am J Gastroenterol (1997) 0.79
Diets causing taurine depletion in cats substantially elevate postprandial plasma cholecystokinin concentration. J Nutr (1995) 0.78
Effects of benzodiazepines on responses of guinea-pig ileum and gall-bladder and rat pancreatic acini to cholecystokinin. Eur J Pharmacol (1986) 0.78
Studies on the renin response to vasoactive intestinal polypeptide (VIP) in the conscious rabbit. Br J Pharmacol (1983) 0.78
Comparison of the effects of concanavalin-A and epidermal growth factor on epithelial cell proliferation in the rat intestine. Aliment Pharmacol Ther (2001) 0.78
Accelerated in vitro degradation of CCK-58 in blood and plasma of patients with acute pancreatitis. Clin Chim Acta (1991) 0.78
Helicobacter pylori stimulates granulocyte-macrophage colony-stimulating factor (GM-CSF) production from cultured antral biopsies and a human gastric epithelial cell line. Eur J Gastroenterol Hepatol (1997) 0.78
Analysis of N(alpha)-methylhistamine by gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl (2000) 0.78
Helicobacter pylori infection and tumour necrosis factor-alpha increase gastrin release from human gastric antral fragments. Eur J Gastroenterol Hepatol (1997) 0.78
Effects of Ostertagia ostertagi and omeprazole treatment on feed intake and gastrin-related responses in the calf. Vet Parasitol (2002) 0.78
Soybean agglutinin stimulated cholecystokinin release from cultured rabbit jejunal cells requires calcium influx via L-type calcium channels. Peptides (1998) 0.78
Systemic effect of peanut agglutinin following intravenous infusion into rats. Aliment Pharmacol Ther (2000) 0.77
Future treatment of peptic ulcers. Scand J Gastroenterol Suppl (1985) 0.77
Lectins: from basic science to clinical application in cancer prevention. Expert Opin Investig Drugs (1998) 0.77
Inhibiting acid and Helicobacter pylori? Gut (1997) 0.77
Vipoma and watery diarrhea. N Engl J Med (1982) 0.77
Hypergastrinaemia: a new mechanism. Lancet (1991) 0.77